Products
-
- BBB DamageCategories
- Neurotransmitter Antibodies & Receptor Antibodies
- Ionotropic Receptor AntibodiesMetabotropic Receptor AntibodiesNeurotransmitter AntibodiesTransporter AntibodiesSignal Channel Antibodies
- Calcium Channel AntibodiesChloride Channel AntibodiesDense-Core Vesicles AntibodiesNitric Oxide Channel AntibodiesStroke Pathology Antibodies
- Neurogenesis AntibodiesNeuronal Growth & Development AntibodiesNeuronal Growth & Development AntibodiesNeuronal Metabolism AntibodiesSignal Transduction AntibodiesStroke-Related Cell Markers Antibodies
- Glial Cell Marker AntibodiesNeural Stem Cell Marker AntibodiesNeuron Marker AntibodiesSynaptic Marker AntibodiesCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
TYRO3 Blocking Peptide (AC1136)
Cat.#: ACPP-1136
Specifications
Despition TYRO3 Blocking Peptide for Immunocompeition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1518 Human MANF Protein, His (AC1518) 5 µg inquiry ACPP-1709 Human GPC4 Protein (AC1709) 2 µg inquiry ACPP-1123 Recombinant Rat GFAP Protein (AC1123) 25 µl inquiry ACPP-1593 Human MED7 Protein (AC1593) 5 µg inquiry ACPP-1417 Human STMN3 Protein (AC1417) 2 µg inquiry ACPP-1692 Human GLUL Protein (AC1692) 5 µg inquiry ACPP-1847 Human GFRA3 Protein (AC1847) 5 µg inquiry ACPP-1346 GFAP Blocking Peptide (AC1346) 250 µg inquiry ACPP-1408 Human SH3GL3 Protein (AC1408) 5 µg inquiry ACPP-1264 SorLA Blocking Peptide (AC1264) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket